Camp4 Therapeutics Corporation (CAMP)

NASDAQ: CAMP · Real-Time Price · USD

4.340

+0.140 (3.33%)

At close: Jun 23, 2026, 4:00 PM EDT

4.627

+0.287 (6.61%)

After-hours: Jun 23, 2026, 7:28 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Biotechnology (Startups)	3.50M	652.00K	350.00K
Biotechnology (Startups) Growth	436.50%	86.29%	-
Total	3.50M	652.00K	350.00K
Total Growth	436.50%	86.29%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	3.50M	652.00K	350.00K
United States Growth	436.50%	86.29%	-
Total	3.50M	652.00K	350.00K
Total Growth	436.50%	86.29%	-